Tahoe Therapeutics
Tahoe, formerly Vevo Therapeutics, is a biotechnology company pioneering AI-driven drug discovery using its Mosaic platform, which generates scalable in vivo single-cell precision data capturing patient diversity in drug response. This platform creates the world's largest atlas of how drugs interact with patient cells, enabling AI models to discover novel therapeutic targets and drugs undetectable by traditional methods. Tahoe focuses on cancer drug discovery, leveraging gigascale single-cell maps and virtual cell models to improve drug design and efficacy. The company is backed by prominent investors and led by founders with expertise in genomics, computational biology, and chemistry, positioning it as a leader in next-generation drug discovery technology.
Tahoe Therapeutics
Tahoe, formerly Vevo Therapeutics, is a biotechnology company pioneering AI-driven drug discovery using its Mosaic platform, which generates scalable in vivo single-cell precision data capturing patient diversity in drug response. This platform creates the world's largest atlas of how drugs interact with patient cells, enabling AI models to discover novel therapeutic targets and drugs undetectable by traditional methods. Tahoe focuses on cancer drug discovery, leveraging gigascale single-cell maps and virtual cell models to improve drug design and efficacy. The company is backed by prominent investors and led by founders with expertise in genomics, computational biology, and chemistry, positioning it as a leader in next-generation drug discovery technology.